Luitpold Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Luitpold Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011906
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Luitpold Pharmaceuticals Inc (Luitpold), a subsidiary of Daiichi Sankyo Company Ltd is a manufacturer and marketer of drugs and medical devices. The company provides injectable parenteral medications that are used in pharmacy admixtures and nutrient solutions, antidotes, critical care drugs, diluents and medicinal dyes. Its service portfolio includes contract manufacturing, product development, analytical development, regulatory and documentation support, raw material testing, stability testing, warehousing and distribution, labeling and packaging development, among others. The company caters to pharmaceutical, healthcare professionals, clinics, and hospitals. It operates in the US and Canada. Luitpold is headquartered in Shirley, New York, the US.

Luitpold Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Luitpold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Luitpold Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Luitpold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Luitpold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Luitpold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Luitpold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Oragenics Enters Into Licensing Agreement With PharmaForce 10
Asset Transactions 11
Amring Pharma Acquires Six ANDAs from Luitpold Pharma and AlphaForce 11
Egalet Acquires SPRIX Nasal Spray from Luitpold Pharma 12
Luitpold Pharmaceuticals Inc – Key Competitors 14
Luitpold Pharmaceuticals Inc – Key Employees 15
Luitpold Pharmaceuticals Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Luitpold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Luitpold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Luitpold Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Luitpold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Luitpold Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Luitpold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Oragenics Enters Into Licensing Agreement With PharmaForce 10
Amring Pharma Acquires Six ANDAs from Luitpold Pharma and AlphaForce 11
Egalet Acquires SPRIX Nasal Spray from Luitpold Pharma 12
Luitpold Pharmaceuticals Inc, Key Competitors 14
Luitpold Pharmaceuticals Inc, Key Employees 15
Luitpold Pharmaceuticals Inc, Subsidiaries 16

★海外企業調査レポート[Luitpold Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BirchBioMed Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BirchBioMed Inc (BirchBioMed) is a biomedical company that concentrate on the development, clinical evaluation and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company’s proprietary and patented lead drug candidate, FS2 is be …
  • Sumitomo Heavy Industries Construction Cranes Co., Ltd.
    Sumitomo Heavy Industries Construction Cranes Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Heavy Industries Construction Cranes Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • University of Dundee-製薬・医療分野:企業M&A・提携分析
    Summary University of Dundee (Dundee) is an educational research university that offers a range of undergraduate, postgraduate, postgraduate research degree, distant learning and English language programs. The university offers a wide range of academic and research courses in various disciplines suc …
  • TE Connectivity Ltd (TEL):企業の財務・戦略的SWOT分析
    TE Connectivity Ltd (TEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Maersk Line AS:企業の戦略的SWOT分析
    Maersk Line AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Immunodiagnostic Systems Holdings plc (IDH):製品パイプライン分析
    Summary Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research area …
  • Grupo Grana y Montero SAA (GRAMONC1):企業の財務・戦略的SWOT分析
    Grupo Grana y Montero SAA (GRAMONC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Handelsbanken Great Britain:企業の戦略・SWOT・財務分析
    Handelsbanken Great Britain - Strategy, SWOT and Corporate Finance Report Summary Handelsbanken Great Britain - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Muang Thai Insurance PCL:企業の戦略・SWOT・財務情報
    Muang Thai Insurance PCL - Strategy, SWOT and Corporate Finance Report Summary Muang Thai Insurance PCL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • AB Orlen Lietuva:企業の戦略的SWOT分析
    AB Orlen Lietuva - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • The Baltimore Life Insurance Co:企業の戦略・SWOT・財務分析
    The Baltimore Life Insurance Co - Strategy, SWOT and Corporate Finance Report Summary The Baltimore Life Insurance Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • MDU Resources Group Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    MDU Resources Group Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary MDU Resources Group, Inc. (MDU) is an energy, and construction materials and services company. It mines aggregates and markets crushed stone, sand, gravel and related construction materials. The …
  • Britannia Industries Ltd (BRITANNIA):企業の財務・戦略的SWOT分析
    Britannia Industries Ltd (BRITANNIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • WellCare Health Plans Inc (WCG)-製薬・医療分野:企業M&A・提携分析
    Summary WellCare Health Plans Inc (WellCare) is a managed care service provider which focuses on providing government-sponsored managed care services to families, children, seniors and individuals with complex medical needs. The company offers Medicaid health plans, Medicare Advantage (MA) coordinat …
  • LG International Corp (001120):企業の財務・戦略的SWOT分析
    LG International Corp (001120) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Rockhopper Exploration PLC (RKH):企業の財務・戦略的SWOT分析
    Summary Rockhopper Exploration Plc (Rockhopper Exploration) is an oil and gas company that acquires, explores and produces crude oil and natural gas properties in the Falkland Islands and the Greater Mediterranean region. The company’s portfolio of production licenses includes PL003a, PL003b, PL004a …
  • Optus Inc:企業の戦略的SWOT分析
    Optus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Otsuka Pharmaceutical Co Ltd-医療機器分野:企業M&A・提携分析
    Summary Otsuka Pharmaceutical Co Ltd (OPC), a subsidiary of Otsuka Holdings Co Ltd is a provider of healthcare products. The company offers products which include pocari sweat, pocari sweat ion water, oronamin c, calorie mate, nature made, jerubure, jarinea, five mini, amino-value, enerugen, jog mat …
  • Meiji Co Ltd:企業の戦略・SWOT・財務情報
    Meiji Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Meiji Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Midas Group Ltd:企業の戦略・SWOT・財務情報
    Midas Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Midas Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆